This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 01 Mar 2022  |  Europe  |  Mega Trends

    European Clinical Laboratory Services Growth Opportunity

    Customer Experience Driven by New B2B and B2C Business Models

    Diagnostics is the backbone of the healthcare sector. According to a World Health Organization (WHO) study, although the segment accounts for less than 5% of hospital costs, its findings influence 60–70% of healthcare decision-making. Diagnostics helps to analyze medical conditions and guide patients toward the right medication, treatment, or sur...

    $2,450.00
  2. 28 Feb 2022  |  North America  |  Mega Trends

    United States Clinical Laboratory Services Growth Opportunities

    Advanced Molecular Diagnostics and At-Home Testing are Growth Prerequisites

    The United States spends more than $3 trillion—nearly 18% of GDP—on healthcare, a massive sector. Healthcare value chain participants face dynamic environments that several trends impact, including the rise in the aging population (16.9% in 2020); chronic disease burden; regulatory challenges; integration across the care continuum; migration to...

    $2,450.00
  3. 22 Feb 2022  |  North America  |  Mega Trends

    United States Liquid Biopsy Growth Opportunities

    Non-invasive Liquid Biopsy Technology Shapes the Precision Diagnostics Landscape

    Healthcare is rapidly becoming patient-centric, focusing on outcomes and value. This offers clinical diagnostics players opportunities to advance their instrument, assay, and informatics capabilities to address unmet clinical needs and increase the precision diagnostics portfolio. Advances in next-generation sequencing-based companion diagnosti...

    $4,950.00
  4. 15 Feb 2022  |  North America  |  Mega Trends

    Global Biologics Contract Development and Manufacturing Organization Profiles and Growth Opportunities

    The Contract Research, Development, and Manufacturing Organization Business Model to Drive Future Growth Potential

    Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...

    $2,450.00
  5. 17 Jan 2022  |  Global  |  Technology Research

    Global Advances in Omics Technologies Enable Future Drug Discovery and Growth Opportunities

    Emerging Omics Platforms Drive Precision Drug Discovery

    For a long time, drug discovery followed the same path and used conventional analysis methods for proposed targets. Today, changes in technology and the ability to study omics are transforming drug development. Personalized therapy is on the rise and promises to be more effective and efficient in addressing challenges. With growing interest in ...

    $4,950.00